Literature DB >> 10232866

The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori.

T Wada1, Y Aiba, K Shimizu, A Takagi, T Miwa, Y Koga.   

Abstract

BACKGROUND: It remains unclarified whether bovine lactoferrin (bLF) can exert a therapeutic effect on the host infected with Helicobacter pylori.
METHODS: Germfree BALB/c mice were orally inoculated with H. pylori to induce infection. Three weeks after infection the mice were given bLF orally once daily for 2 or 4 weeks and were then killed to examine the bacterial number in the stomach and the serum antibody titer to H. pylori. To count the number of epithelium-bound H. pylori, the resected stomach was agitated in phosphate-buffered saline to remove non-bound H. pylori before bacterial enumeration.
RESULTS: The administration of 10 mg bLF for 3 to 4 weeks decreased the number of H. pylori in the stomach to one-tenth and also exerted a significant inhibitory effect on the attachment of H. pylori to the stomach. As a result, the serum antibody titer to H. pylori, whose level is presumed to represent the size of the immune response by the host, thereby reflecting the degree of bacterial attack, decreased to an undetectable level.
CONCLUSIONS: These findings suggest that bLF exerts an inhibitory effect on colonizing H. pylori by detaching the bacterium from the gastric epithelium and by exerting a direct anti-bacterial effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232866     DOI: 10.1080/00365529950173627

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

Review 1.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Clearance of Escherichia coli O157:H7 infection in calves by rectal administration of bovine lactoferrin.

Authors:  E Kieckens; J Rybarczyk; L De Zutter; L Duchateau; D Vanrompay; E Cox
Journal:  Appl Environ Microbiol       Date:  2014-12-19       Impact factor: 4.792

3.  Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils.

Authors:  Tetsuro Okamoto; Toyohiro Tanida; Benjuan Wei; Eisaku Ueta; Tetsuya Yamamoto; Tokio Osaki
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.

Authors:  T Tanida; F Rao; T Hamada; E Ueta; T Osaki
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 5.  Efficacy of fermented milk and whey proteins in Helicobacter pylori eradication: a review.

Authors:  Aarti Sachdeva; Swapnil Rawat; Jitender Nagpal
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 6.  Natural products and food components with anti-Helicobacter pylori activities.

Authors:  Hiroaki Takeuchi; Vu Thu Trang; Norihito Morimoto; Yoshie Nishida; Yoshihisa Matsumura; Tetsuro Sugiura
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 7.  Engineering immunity in the mammary gland.

Authors:  Andreas F Kolb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

8.  Usefulness of a Helicobacter pylori stool antigen test for diagnosing H. pylori infected C57BL/6 mice.

Authors:  Dae-In Moon; Eun-Hye Shin; Hong-Geun Oh; Jin-Sik Oh; Sunhwa Hong; Yungho Chung; Okjin Kim
Journal:  Lab Anim Res       Date:  2013-03-25

9.  Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.

Authors:  Antonio Francesco Ciccaglione; Mara Di Giulio; Silvia Di Lodovico; Emanuela Di Campli; Luigina Cellini; Leonardo Marzio
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

10.  The prospects of modifying the antimicrobial properties of milk.

Authors:  A F Kolb
Journal:  Biotechnol Adv       Date:  2001-07       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.